Pre-sleep Protein Supplementation and Load Carriage Recovery in British Army Recruits
Pre-sleep Protein Supplementation Does Not Improve Recovery From Load Carriage in British Army Recruits
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Cambridgeshire
-
Cambridge, Cambridgeshire, United Kingdom, CB1 1PT
- Anglia Ruskin University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Enrolled into British Army basic training
- Medically fit to train and complete the load carriage test
Exclusion Criteria:
- Not taking any other nutritional supplement
- Pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: High protein intake supplementation
A 60g daily dose of whey protein supplementation
|
The participants received a 60g whey protein bolus each evening prior to sleep pre and post a military load carriage test.
|
|
Experimental: Moderate protein intake supplementation
A 20g dose of whey protein supplementation
|
The participants received a 20g whey protein bolus each evening prior to sleep pre and post a military load carriage test.
|
|
Placebo Comparator: Carbohydrate placebo
An isocaloic maltodextrin carbohydrate placebo
|
The participants received an isocaloric carbohydrate bolus each evening prior to sleep pre and post a military load carriage test.
|
|
Other: Control group, no supplementation
Control group, not taking any supplementation, only completing basic training activities
|
Control group, no supplementation, only basic training
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in lower body muscle function
Time Frame: 40-hours
|
The change in maximal vertical jump height in participants before and after the load carriage test
|
40-hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change in urinary myoglobin
Time Frame: 40-hours
|
The relative change in concentration of urinary myoglobin (ng/ml) in participants before and after the load carriage test
|
40-hours
|
|
The change in urinary 3-methylhistidine
Time Frame: 40-hours
|
The relative change in concentration of urinary 3-methylhistidine (nmol/ml) in participants before and after the load carriage test
|
40-hours
|
|
The change in perceived muscle soreness
Time Frame: 40-hours
|
The relative change in perceived muscle soreness assessed via visual analogue scale.
The participants were asked to record their perceived muscle soreness using a 0-10 Likert scale (e.g., 0=no pain, 10=severe pain that limits the ability to move).
|
40-hours
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Justin D Roberts, PhD, Anglia Ruskin University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1076/MODREC/20B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.